Catalyst4, Inc. bought MLPT
August 14, 2026 · Form 4 insider transaction
Catalyst4, Inc. bought 4,400,000 shares of MapLight Therapeutics, Inc. at $11.38 per share, a transaction worth $50.07M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,400,000
Price
$11.38
Total value
$50.07M
InsiderCatalyst4, Inc.
Role10% owner
SecurityVoting Common Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 14, 2026
Filing dateAugust 18, 2026
Shares owned after25,306,689
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.